110 related articles for article (PubMed ID: 21717524)
1. Prognostic significance of RB1-inducible coiled-coil 1 in salivary gland cancers.
Tameno H; Chano T; Ikebuchi K; Ochi Y; Arai A; Kishimoto M; Shimada T; Hisa Y; Okabe H
Head Neck; 2012 May; 34(5):674-80. PubMed ID: 21717524
[TBL] [Abstract][Full Text] [Related]
2. RB1CC1 together with RB1 and p53 predicts long-term survival in Japanese breast cancer patients.
Chano T; Ikebuchi K; Tomita Y; Jin Y; Inaji H; Ishitobi M; Teramoto K; Ochi Y; Tameno H; Nishimura I; Minami K; Inoue H; Isono T; Saitoh M; Shimada T; Hisa Y; Okabe H
PLoS One; 2010 Dec; 5(12):e15737. PubMed ID: 21203526
[TBL] [Abstract][Full Text] [Related]
3. Concomitant expression of ezrin and HER2 predicts distant metastasis and poor prognosis of patients with salivary gland carcinomas.
Hashimoto K; Hayashi R; Mukaigawa T; Yamazaki M; Fujii S
Hum Pathol; 2017 May; 63():110-119. PubMed ID: 28300573
[TBL] [Abstract][Full Text] [Related]
4. Programmed death ligand-1 expression is associated with poor disease free survival in salivary gland carcinomas.
Mukaigawa T; Hayashi R; Hashimoto K; Ugumori T; Hato N; Fujii S
J Surg Oncol; 2016 Jul; 114(1):36-43. PubMed ID: 27111278
[TBL] [Abstract][Full Text] [Related]
5. ELMO3 - a Negative Prognostic Marker in Minor Salivary Gland Carcinoma.
Kotowski U; Kadletz L; Schneider S; Oberndorfer F; Erovic BM; Grasl MC; Lill C; Heiduschka G
Pathol Oncol Res; 2019 Apr; 25(2):585-591. PubMed ID: 30374620
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of DCLK1 is predictive for recurrent disease in major salivary gland malignancies.
Kadletz L; Aumayr K; Heiduschka G; Schneider S; Enzenhofer E; Lill C
Eur Arch Otorhinolaryngol; 2017 Jan; 274(1):467-475. PubMed ID: 27470117
[TBL] [Abstract][Full Text] [Related]
7. High expression of H3K9me3 is a strong predictor of poor survival in patients with salivary adenoid cystic carcinoma.
Xia R; Zhou R; Tian Z; Zhang C; Wang L; Hu Y; Han J; Li J
Arch Pathol Lab Med; 2013 Dec; 137(12):1761-9. PubMed ID: 24283856
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical expression profiles of mucin antigens in salivary gland mucoepidermoid carcinoma: MUC4- and MUC6-negative expression predicts a shortened survival in the early postoperative phase.
Honjo K; Hiraki T; Higashi M; Noguchi H; Nomoto M; Yoshimura T; Batra SK; Yonezawa S; Semba I; Nakamura N; Tanimoto A; Yamada S
Histol Histopathol; 2018 Feb; 33(2):201-213. PubMed ID: 28649694
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of 1p36 locus deletion in adenoid cystic carcinoma of the salivary glands.
Šteiner P; Andreasen S; Grossmann P; Hauer L; Vaněček T; Miesbauerová M; Santana T; Kiss K; Slouka D; Skálová A
Virchows Arch; 2018 Oct; 473(4):471-480. PubMed ID: 29619555
[TBL] [Abstract][Full Text] [Related]
10. High expression level of geminin predicts a poor clinical outcome in salivary gland carcinomas.
Yamazaki M; Fujii S; Murata Y; Hayashi R; Ochiai A
Histopathology; 2010 Jun; 56(7):883-92. PubMed ID: 20497246
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of lymph node density in high-grade salivary gland cancers.
Hong HR; Roh JL; Cho KJ; Choi SH; Nam SY; Kim SY
J Surg Oncol; 2015 May; 111(6):784-9. PubMed ID: 25640975
[TBL] [Abstract][Full Text] [Related]
12. RB1CC1 activates RB1 pathway and inhibits proliferation and cologenic survival in human cancer.
Chano T; Ikebuchi K; Ochi Y; Tameno H; Tomita Y; Jin Y; Inaji H; Ishitobi M; Teramoto K; Nishimura I; Minami K; Inoue H; Isono T; Saitoh M; Shimada T; Hisa Y; Okabe H
PLoS One; 2010 Jun; 5(6):e11404. PubMed ID: 20614030
[TBL] [Abstract][Full Text] [Related]
13. Ataxia-Telangiectasia-Mutated Protein Expression as a Prognostic Marker in Adenoid Cystic Carcinoma of the Salivary Glands.
Bazarsad S; Kim JY; Zhang X; Kim KY; Lee DY; Ryu MH; Kim J
Yonsei Med J; 2018 Aug; 59(6):717-726. PubMed ID: 29978608
[TBL] [Abstract][Full Text] [Related]
14. RB1CC1 suppresses cell cycle progression through RB1 expression in human neoplastic cells.
Kontani K; Chano T; Ozaki Y; Tezuka N; Sawai S; Fujino S; Saeki Y; Okabe H
Int J Mol Med; 2003 Nov; 12(5):767-9. PubMed ID: 14533007
[TBL] [Abstract][Full Text] [Related]
15. Minor salivary gland tumors of the oral cavity: a case series with review of literature.
Vaidya AD; Pantvaidya GH; Metgudmath R; Kane SV; D'Cruz AK
J Cancer Res Ther; 2012 Jan; 8 Suppl 1():S111-5. PubMed ID: 22322728
[TBL] [Abstract][Full Text] [Related]
16. Truncating mutations of RB1CC1 in human breast cancer.
Chano T; Kontani K; Teramoto K; Okabe H; Ikegawa S
Nat Genet; 2002 Jul; 31(3):285-8. PubMed ID: 12068296
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of postoperative survival rates of mucoepidermoid carcinoma in salivary gland].
Li CZ; Sun MY; Zhang XH; Luo XL; Sun WB
Zhonghua Kou Qiang Yi Xue Za Zhi; 2006 Dec; 41(12):709-12. PubMed ID: 17349187
[TBL] [Abstract][Full Text] [Related]
18. Five- and 10-Year Cause-Specific Survival Rates in Carcinoma of the Minor Salivary Gland.
Baddour HM; Fedewa SA; Chen AY
JAMA Otolaryngol Head Neck Surg; 2016 Jan; 142(1):67-73. PubMed ID: 26632951
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of p27 and Ki-67 expression in mucoepidermoid carcinoma of the intraoral minor salivary gland.
Okabe M; Inagaki H; Murase T; Inoue M; Nagai N; Eimoto T
Mod Pathol; 2001 Oct; 14(10):1008-14. PubMed ID: 11598171
[TBL] [Abstract][Full Text] [Related]
20. RB1CC1 activates the promoter and expression of RB1 in human cancer.
Ikebuchi K; Chano T; Ochi Y; Tameno H; Shimada T; Hisa Y; Okabe H
Int J Cancer; 2009 Aug; 125(4):861-7. PubMed ID: 19437535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
